Neil H. Segal MD PhD (@segaln) profile picture

GI oncologist, Memorial Sloan Kettering Cancer Center, focusing on colorectal cancer immunotherapy

New York
Joined June 2009
“Early efficacy and encouraging pharmacodynamic evidence suggest the REGN7075 can enhance immune responses and antitumor immunity to “cold” tumors.”    - Gastrointestinal oncologist Dr. @segaln during his oral session at @ASCO. #ASCO24
5
25
3,447
Neil H. Segal MD PhD retweeted
Last debate @GreatDebatesCME on Day 1 w/ Dr. 🤩Neil Segal @MSKCancerCenter and Dr. Michael Overman @MDAndersonNews: Is there a role for IO therapy in MSS (pMMR) patients? #immunotherapy #cancer #cancerresearch Yes or no? More GREAT speakers tomorrow on Day 2 👏@YJanjigianMD
1
7
28
1,733
Our manuscript was published in Nature Communications! The CEA-CD3 T-cell bispecific antibody, cibisatamab, with or without atezolizumab - including MSS-CRC: phase 1/1b trials. rdcu.be/dHYSb
6
226